Indivior is a leading company in the field of addiction treatment, with over 20 years of experience dedicated to understanding the challenges faced by individuals struggling with substance use disorders. The company specializes in the development, manufacture, and sale of prescription medications designed to address addiction and other serious mental health issues. Its product portfolio includes notable treatments such as Sublocade, Perseris, Suboxone, and Opvee. Indivior emphasizes a patient-focused approach, recognizing that individuals with addiction often face stigma, leading to under-diagnosis and insufficient support. The majority of Indivior's revenue is generated in the United States, followed by the United Kingdom and other international markets.
Scientia Vascular
Private Equity Round in 2024
Scientia Vascular, LLC is a medical device company based in Salt Lake City, Utah, founded in 2008. It specializes in the development, manufacture, and marketing of endovascular medical devices, particularly for neuro, peripheral, and coronary vascular access applications. One of its notable products is PLATO, a micro-catheter designed for the treatment of hemorrhagic and ischemic strokes. The company utilizes advanced micromachining and microfabrication techniques to create innovative devices that enhance performance and facilitate complex, minimally invasive procedures. By focusing on the evolving needs of interventional specialists, Scientia Vascular aims to improve patient outcomes through its high-precision medical devices and therapies.
Integrity Orthopaedics
Series B in 2024
Integrity Orthopaedics specializes in the development and distribution of a pioneering rotator cuff repair device. This innovative product addresses traditional limitations by providing robust initial repair strength, minimal tendon mobility, broad fixation points, and an optimal biologic environment for healing. The company's mission is to revolutionize soft tissue repair, enhancing patient outcomes and recovery.
Moxe Health specializes in facilitating the exchange of clinical data between health plans and provider systems. Its platform, Substrate, enables real-time, bi-directional data transfer, including clinical, analytic, and administrative information. Moxe's solutions cover risk adjustment, quality metrics (like HEDIS and Star ratings), claims management, and care gap management, ensuring health plans and providers have the necessary data for value-based care. The company's neutrality allows seamless integration with existing systems, maximizing investments in population health and analytics.
Paragon 28
Series B in 2020
Paragon 28, Inc. is a medical device company specializing in products for foot and ankle surgery. Incorporated in 2010 and based in Englewood, Colorado, with an additional headquarters in Dublin, Ireland, the company offers a comprehensive range of surgical solutions, including plates, screws, allograft bone systems, and interference screws for various orthopedic procedures. Its product portfolio features advanced systems such as the PHANTOM Lapidus Intramedullary Nail for arthrodesis correction, the Proximal Rotational Metatarsal Osteotomy for bunion correction, and the Paratrooper Plantar Plate Repair System for plantar plate repairs. Paragon 28 aims to meet the diverse needs of foot and ankle surgeries through its nearly 80 product systems, addressing conditions such as hallux valgus, fracture fixation, and flat foot. The company primarily generates revenue from the United States market.
Akoya Biosciences
Series D in 2019
Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.
Clinicient
Venture Round in 2019
Clinicient, Inc. is a technology company specializing in software solutions for physical therapy and outpatient rehabilitation clinics. Founded in 1998 and based in Portland, Oregon, Clinicient provides a comprehensive suite of services including electronic medical records (EMR), billing software, and revenue cycle management solutions. Its key offerings include TotalInsight, which integrates cloud-based EMR with outsourced billing services and data-driven coaching, and PracticeInsight, a unified system for EMR and billing. Clinicient also develops customized EMR solutions for therapy providers, as well as Medicare-related services such as functional limitation reporting and claim management. The company's platform aims to enhance operational efficiency for its clients by optimizing payments, minimizing denials, and streamlining billing processes.
Sandler O’Neill & Partners
Acquisition in 2019
Sandler O’Neill + Partners is a full-service investment banking firm and broker-dealer focused on the financial services sector. Its clients include a wide variety of financial firms nationwide, and increasingly, around the globe. The firm provides the full suite of investment banking services, including merger and acquisition advisory, capital markets, fixed income and equity trading and sales, equity research, balance sheet management, mortgage finance and consulting services to financial institutions and their investors. Sandler O’Neill is a partnership, and different by design. Since the firm’s founding in 1988, its partners have sought to provide banks, thrifts and other financial services companies with an alternative to large Wall Street banking firms. The firm's focus has always been to enhance franchise value for clients within known, managed risk parameters. We provide clients a wealth of experience and knowledge more critical to them today than ever.
Elligo Health Research
Series C in 2019
Elligo Health Research, Inc. is a healthcare organization focused on improving the clinical research landscape by bringing research directly to healthcare clinics. Founded in 2016 and headquartered in Austin, Texas, the company utilizes advanced healthcare informatics and electronic health records to enhance patient and physician participation in clinical trials. By enabling physicians to conduct trials within their practices, Elligo eliminates common barriers related to patient enrollment and study delays, while providing essential infrastructure and support. This approach not only accelerates the development of new pharmaceutical, biotechnology, and medical device products but also ensures that patients benefit from access to cutting-edge therapies without the logistical challenges of traditional trials. Elligo's model empowers physicians and offers patients the opportunity to contribute to clinical research, ultimately fostering advancements in healthcare for future generations.
Weeden
Acquisition in 2019
Weeden & Co. is an employee-owned limited partnership based in Greenwich, Connecticut, specializing in global trading solutions. The firm focuses on execution services, utilizing program trading, proprietary algorithmic strategies, and derivatives. Its platform offers a range of services, including global cash trading, electronic trading, and equity derivatives trading. The company emphasizes teamwork and loyalty among its employees, which enhances its ability to listen to clients and deliver superior execution solutions. This structure not only fosters a collaborative environment but also aligns the success of the firm with the interests of its employees and clients.
Foodsby LLC is a Minneapolis-based company that operates an online marketplace designed to connect office employees with local restaurants for convenient lunch delivery. Founded in 2012, Foodsby allows individuals in office buildings to place orders through its website, where these orders are aggregated and delivered collectively by restaurants. This service not only offers a diverse selection of meal options from both local and national restaurant brands but also aims to enhance productivity by providing easy access to quality lunches. By streamlining the delivery process, Foodsby enables busy professionals to enjoy a variety of meals while maintaining their work efficiency.
Xenex
Venture Round in 2017
Xenex is a company dedicated to reducing healthcare-associated infections (HAIs) through its innovative disinfection technology. Founded in 2009 and headquartered in San Antonio, Texas, Xenex develops a portable ultraviolet room disinfection system that employs pulsed xenon UV light to effectively eliminate harmful microorganisms, including bacteria and viruses, in healthcare environments. Since its commercial introduction in 2010, Xenex's devices have been integrated into infection control protocols in nearly three hundred hospitals across the United States. The company's mission focuses on saving lives and alleviating suffering by significantly lowering the bacterial load that contributes to the risk of HAIs, thereby protecting patients, healthcare staff, and the financial health of medical facilities.
OrthoAccel Technologies
Series C in 2017
OrthoAccel Technologies, Inc. is a medical device company focused on developing innovative products for dental care and orthodontic treatment. It offers the AcceleDent Optima, an orthodontic device that connects patients and dental practices while monitoring tooth movement, and the AcceleDent Aura, which utilizes SoftPulse technology to produce gentle micro pulses that accelerate bone remodeling. The product line includes an activator, mouthpiece, USB extension cable with power adapter, and a travel case. OrthoAccel sells its devices through orthodontic practices across the United States and internationally. Founded in 2006 and headquartered in Bellaire, Texas, the company has a strong focus on advancing orthodontic treatment through its proprietary technologies.
Torax Medical
Series E in 2016
Torax Medical, Inc. is a clinical stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters, primarily for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence. Its flagship product, the LINX reflux management system, utilizes specialized magnets to provide a minimally invasive solution for patients suffering from GERD. Additionally, Torax offers the FENIX continence restoration system, designed to address fecal incontinence. The company's products are available in both the United States and Europe, reflecting its commitment to improving patient outcomes in the field of digestive diseases. Torax Medical operates as a subsidiary of Ethicon, Inc.
Norsk Titanium
Venture Round in 2016
Norsk Titanium AS is a Norwegian company specializing in the design and manufacture of 3D-printed titanium production machinery, primarily serving the aerospace industry. Founded in 2004 and based in Hønefoss, Norway, with additional operations in Plattsburgh, New York, the company utilizes its patented Rapid Plasma Deposition (RPD) technology to produce structural titanium parts. This technology involves melting titanium wire in a controlled environment and building it up layer by layer, resulting in near-net-shape components that require minimal finishing. The process is significantly more cost-effective than traditional manufacturing methods, reducing production costs by 50% to 75%. Norsk Titanium's products are used in high-complexity markets such as aerospace, defense, and commercial industries like oil and gas.
OrthoAccel Technologies
Series C in 2016
OrthoAccel Technologies, Inc. is a medical device company focused on developing innovative products for dental care and orthodontic treatment. It offers the AcceleDent Optima, an orthodontic device that connects patients and dental practices while monitoring tooth movement, and the AcceleDent Aura, which utilizes SoftPulse technology to produce gentle micro pulses that accelerate bone remodeling. The product line includes an activator, mouthpiece, USB extension cable with power adapter, and a travel case. OrthoAccel sells its devices through orthodontic practices across the United States and internationally. Founded in 2006 and headquartered in Bellaire, Texas, the company has a strong focus on advancing orthodontic treatment through its proprietary technologies.
Simmons & Company International
Acquisition in 2015
Simmons & Company International is one of the largest and most experienced independent investment banks specializing in the energy industry, offering unparalleled M&A advisory, capital markets execution and investment research. By leveraging the collective knowledge of their growing team of approximately 150 professionals, they stay on the forefront of the industry's trends, drivers and developments and are also positioned to access the most strategic opportunities for their clients. Over the last four decades they have established theirselves as a premier partner in virtually every energy sector, serving a worldwide client base ranging from institutional investors, public and private companies and private equity firms. Their extensive market coverage and industry knowledge has not only profoundly shaped their unique perspective, but empowers clients to understand the energy sector in a new light.
GutCheck is a provider of an online qualitative market research platform that focuses on addressing critical business questions. The company employs innovative technology and agile human experience intelligence to offer clients insights that enhance their decision-making throughout the innovation cycle. By prioritizing authentic and contextualized human experiences, GutCheck helps brands better understand their target audiences, allowing them to create improved experiences across various customer touchpoints. The platform is designed to deliver quick, economical, and convenient services at scale, empowering innovative brands to unlock new possibilities and effectively navigate the complexities of market research.
PerfectServe
Series D in 2015
PerfectServe, Inc. is a healthcare technology company based in Knoxville, Tennessee, that specializes in secure communications and collaboration solutions for the healthcare industry in the United States. Founded in 1999, the company provides a comprehensive platform that includes clinical communication, provider scheduling, nurse communication, and medical answering services. Its offerings, such as PerfectServe Synchrony and PerfectServe One-2-One, facilitate effective communication between physicians, nurses, and other healthcare providers, enhancing patient care and operational efficiency. The platform is designed to ensure accuracy, reliability, and personal control over communication processes, supporting hospitals, physician practices, and healthcare clients across more than 130 markets. PerfectServe's services enable tens of thousands of daily interactions, connecting medical professionals with approximately 12 million patients, thereby underscoring the growing demand for innovative healthcare communication solutions. The company has seen significant growth, with compound annual growth rates exceeding 50 percent since 2000.
River Branch Holdings
Acquisition in 2015
River Branch Holdings LLC is an international merchant bank based in Chicago, Illinois, founded in 2010. The firm specializes in providing a variety of investment banking and investment management services, including mortgage banking, asset management, mergers and acquisitions advisory, and recapitalization. With over 100 years of combined expertise among its team, River Branch Holdings focuses on delivering tailored solutions to clients in sectors such as technology, financial services, and healthcare. The firm emphasizes building long-term partnerships with clients, investors, and stakeholders to foster insightful knowledge and hands-on experience. In 2015, River Branch Holdings became a subsidiary of Piper Jaffray Companies.
Lattice Engines
Series D in 2015
Lattice Engines, Inc. is a software company that specializes in predictive applications for marketing and sales organizations. Founded in 2006 and headquartered in San Mateo, California, the company offers a range of solutions designed to enhance marketing and sales performance through data-driven insights. Its flagship product, Lattice Atlas, utilizes artificial intelligence to integrate multiple data sources and build targeted audiences. Additional offerings include Lattice for Salesforce, which provides sales analytics; Lattice for Marketo, delivering predictive insights for marketing programs; and tools for predictive lead scoring, customer retention, and hyper-personalized marketing campaigns. Lattice Engines combines internal and external data with proprietary analytics to optimize sales targeting and improve the efficiency of marketing teams. The company also provides professional curriculum services and has a strategic partnership with Engagio Inc. In 2019, Lattice Engines became a subsidiary of The Dun & Bradstreet Corporation, further expanding its capabilities in the field.
SportsEngine
Series D in 2014
SportsEngine, Inc. is a leading provider of web and mobile application software for managing youth, amateur, and professional sports. Founded in 2004 and headquartered in Minneapolis, Minnesota, the company offers a comprehensive suite of management tools designed to assist over 500,000 sports teams, leagues, clubs, and associations. Its product offerings include SportsEngine for team and tournament management, TeamUnify for swim team administration, GoMotion for class-based sports, Trackwrestling for wrestling event management, Tourney Machine for tournament organization, and RallyMe for fundraising. These tools help sports organizations streamline operations and improve communication among various stakeholders, including athletes, parents, coaches, and officials, thereby reducing administrative burdens and enhancing engagement in the sports community.
Edgeview Partners
Acquisition in 2013
Edgeview Partners is a specialized investment bank serving the unique merger and acquisition (M&A) advisory needs of middle-market clients. Founded in 2001, our firm advises clients across the United States and Canada in virtually all industries, typically working with companies ranging in enterprise value from $25 million to $500 million. Our main focus is on the sale of privately held companies backed by entrepreneurs, families or private equity groups, as well as divisions of larger corporations. We also have extensive experience advising on growth capital raises, recapitalization transactions and buy-side acquisitions. Our qualified team of professionals has diverse expertise advising on middle-market mergers and acquisitions, having completed over 350 successful transactions throughout their careers. We combine senior-level commitment and significant resources to deliver unmatched client service. Our creativity and superior results for a broad spectrum of clients have been recognized with numerous industry awards, including recognition by The M&A Advisor as Boutique Investment Bank of the Year and multiple Deal of the Year awards.
Sapphire Digital
Series C in 2013
Sapphire Digital, established in 2007 and headquartered in Lyndhurst, New Jersey, is a healthcare technology company specializing in cost reduction and care selection. It offers a suite of solutions, including CareSelect, SmartShopper, MEG, and Sapphire 360, which empower consumers, employers, and health plans to make informed decisions about their healthcare, driving down costs and improving quality. These platforms facilitate care shopping, reward cost-conscious employees, provide surgeon and facility quality scores, and support data-driven medical spend reduction. The company, formerly known as Vitals, serves over 280 million people annually.
Oncolytics Biotech
Post in 2013
Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company based in Calgary, Canada, dedicated to the discovery and development of innovative cancer therapies. The company's lead product, pelareorep, is an immuno-oncology agent derived from reovirus, designed to treat solid tumors and hematological malignancies by enhancing the immune system's ability to combat cancer. Oncolytics Biotech has established collaboration agreements with Merck KGaA and Pfizer Inc. to explore pelareorep in combination with other treatments for specific types of breast cancer. Additionally, the company is advancing its pipeline with projects such as Bracelet-1 for breast cancer and various cohorts for gastrointestinal cancer. Founded in 1998, Oncolytics Biotech aims to develop effective treatments for cancers that have not responded to existing therapies.
Torax Medical
Series D in 2012
Torax Medical, Inc. is a clinical stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters, primarily for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence. Its flagship product, the LINX reflux management system, utilizes specialized magnets to provide a minimally invasive solution for patients suffering from GERD. Additionally, Torax offers the FENIX continence restoration system, designed to address fecal incontinence. The company's products are available in both the United States and Europe, reflecting its commitment to improving patient outcomes in the field of digestive diseases. Torax Medical operates as a subsidiary of Ethicon, Inc.
Athersys, Inc. is a biotechnology company headquartered in Cleveland, Ohio, specializing in regenerative medicine. The company focuses on the research and development of therapeutic products aimed at treating various disease indications, including neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary issues. Its primary product, MultiStem cell therapy, is an allogeneic stem cell treatment currently undergoing Phase III clinical trials for ischemic stroke and Phase II trials for acute myocardial infarction. Additionally, MultiStem has completed Phase I trials concerning certain blood-borne cancers. Athersys is also dedicated to developing therapies for veterinary applications and has established collaboration agreements with Healios K.K. and the University of Minnesota to further advance its MultiStem platform in several disease contexts. The company has engaged in various revenue-generating activities, including corporate collaborations, licensing agreements, and government grants. Founded in 1995, Athersys is committed to addressing unmet medical needs through innovative biopharmaceuticals.
PerfectServe
Series C in 2012
PerfectServe, Inc. is a healthcare technology company based in Knoxville, Tennessee, that specializes in secure communications and collaboration solutions for the healthcare industry in the United States. Founded in 1999, the company provides a comprehensive platform that includes clinical communication, provider scheduling, nurse communication, and medical answering services. Its offerings, such as PerfectServe Synchrony and PerfectServe One-2-One, facilitate effective communication between physicians, nurses, and other healthcare providers, enhancing patient care and operational efficiency. The platform is designed to ensure accuracy, reliability, and personal control over communication processes, supporting hospitals, physician practices, and healthcare clients across more than 130 markets. PerfectServe's services enable tens of thousands of daily interactions, connecting medical professionals with approximately 12 million patients, thereby underscoring the growing demand for innovative healthcare communication solutions. The company has seen significant growth, with compound annual growth rates exceeding 50 percent since 2000.
Biohorizons.com
Private Equity Round in 2011
BioHorizons is a manufacturer based in Birmingham, Alabama, specializing in dental implant products and tissue regeneration solutions. Since the introduction of the Maestro implant system in 1997, the company has maintained a strong commitment to developing evidence-based, scientifically-proven products. BioHorizons offers a comprehensive portfolio that includes the Tapered Plus and Tapered 3.0 implant systems, in addition to dental instruments and guided system software. Their focus on science, innovation, and customer service has positioned BioHorizons as one of the fastest-growing companies in the dental industry, providing professionals with confidence in their use of the company's advanced dental implants and biologics.
Living Proof
Series B in 2011
Living Proof, Inc. is a hair care product manufacturer based in Cambridge, Massachusetts, founded in 2005. The company specializes in developing innovative hair care solutions that address various beauty challenges through advanced technology and science-backed formulas. Its product range includes shampoos, conditioners, styling treatments, nourishing creams, and a variety of sprays and serums designed to enhance hair health and appearance. Living Proof's formulations are suitable for all hair types, including color-treated hair, ensuring that consumers can achieve their desired results. The company distributes its products via its online store and through salons, retailers, and specialty beauty stores across several countries, including the United States, Canada, the United Kingdom, Australia, Singapore, and Thailand. In August 2008, the company changed its name from Andora, Inc. and has operated as a subsidiary of Unilever PLC since February 2017.
IDev Technologies
Series D in 2010
IDEV Technologies is an emerging growth medical device company that specializes in the development of innovative products for endovascular and interventional applications, particularly within interventional radiology, gastroenterology, vascular surgery, and cardiology. The company markets its flagship product, SUPERA, a self-expanding nitinol stent designed with a patented interwoven structure that enhances flexibility, radial strength, and resistance to kinking and crushing compared to competing stents. SUPERA is approved for treating biliary strictures in the United States and is currently undergoing clinical evaluation in the SUPERB IDE trial to assess its safety and efficacy for use in the superficial femoral artery.
Advisory Research
Acquisition in 2009
Advisory Research, Inc. is a privately owned investment management firm based in Chicago, Illinois, established in 1974. The company specializes in providing customized investment strategies and services primarily to high-net-worth individuals, institutions, corporations, and government entities. Advisory Research manages separate client-focused equity portfolios and offers private funds, including equity mutual funds and hedge funds. The firm invests globally in public equity and fixed income markets, with a focus on value stocks across various market capitalizations, including micro-cap, small-cap, mid-cap, and large-cap companies. Utilizing a fundamental analysis approach and in-house research, the firm emphasizes a bottom-up stock picking strategy to identify investment opportunities. As a subsidiary of Ostara Inc., Advisory Research is committed to delivering competitive risk-adjusted returns and personalized client service through a collaborative and entrepreneurial culture.
Pandora Media
Series F in 2009
Pandora Media, LLC is a music and podcast discovery platform based in Oakland, California, serving approximately 70 million users each month. Founded in 2000, Pandora utilizes its proprietary Music Genome Project and Podcast Genome Project technologies to deliver personalized music streaming services. Unlike traditional radio, which broadcasts the same content to all listeners, Pandora allows users to create customized stations and playlists, as well as search for and play songs on demand. The platform is accessible via mobile devices, web applications, and approximately 2,000 connected products in homes and vehicles. Pandora generates revenue through an ad-supported radio service, a subscription service called Pandora Plus, and an on-demand service known as Pandora Premium. By leveraging extensive listener data, Pandora enables targeted advertising for both local and national advertisers while providing artists with valuable insights to connect with their audience.
VidaCare
Venture Round in 2009
Vidacare Corporation is a medical device company based in San Antonio, Texas, specializing in intraosseous access technology. Founded in 2001, the company develops, manufactures, and markets devices designed for diagnostic, monitoring, and therapeutic applications, particularly in emergency situations where traditional vascular access is challenging. Its primary product, the EZ-IO Product System, enables controlled vascular access through the intraosseous route, utilizing a power driver that drills through bone to secure placement. Additionally, Vidacare offers a suite of products for hematology and oncology, including tools for bone marrow aspiration and biopsy. Its offerings are utilized in various settings, including pre-hospital care, emergency response, and military applications, addressing critical needs in bone and blood-related medicine.
Pandora Media
Series E in 2009
Pandora Media, LLC is a music and podcast discovery platform based in Oakland, California, serving approximately 70 million users each month. Founded in 2000, Pandora utilizes its proprietary Music Genome Project and Podcast Genome Project technologies to deliver personalized music streaming services. Unlike traditional radio, which broadcasts the same content to all listeners, Pandora allows users to create customized stations and playlists, as well as search for and play songs on demand. The platform is accessible via mobile devices, web applications, and approximately 2,000 connected products in homes and vehicles. Pandora generates revenue through an ad-supported radio service, a subscription service called Pandora Plus, and an on-demand service known as Pandora Premium. By leveraging extensive listener data, Pandora enables targeted advertising for both local and national advertisers while providing artists with valuable insights to connect with their audience.
eFashion Solutions
Venture Round in 2006
eFashionSolutions is the leading provider of online flagship stores to the branded fashion apparel/accessories, entertainment, and specialty retail industries. The eFashionSolutions e-commerce services are supported by a comprehensive technology platform. Services include buying and merchandising, design, photography, e-marketing, business intelligence, customer service, order management, and fulfillment functions. The Company is led by apparel and retail executives with extensive experience in merchandising, branding, customer service, and the technology solutions required to effectively manage and grow an online retail business. In 2006, eFashionSolutions was named to the Inc. 500 and NJ Finest 50. In 2007, the company received the USPS Strategic Business Development Award for their global shipping program, was named a finalist by the Extended Retail Institute in the Multi-Channel category, and received a Webby Award Nomination for DKNY.com. eFashionSolutions ships to over 120 countries internationally.
Pandora Media
Series D in 2006
Pandora Media, LLC is a music and podcast discovery platform based in Oakland, California, serving approximately 70 million users each month. Founded in 2000, Pandora utilizes its proprietary Music Genome Project and Podcast Genome Project technologies to deliver personalized music streaming services. Unlike traditional radio, which broadcasts the same content to all listeners, Pandora allows users to create customized stations and playlists, as well as search for and play songs on demand. The platform is accessible via mobile devices, web applications, and approximately 2,000 connected products in homes and vehicles. Pandora generates revenue through an ad-supported radio service, a subscription service called Pandora Plus, and an on-demand service known as Pandora Premium. By leveraging extensive listener data, Pandora enables targeted advertising for both local and national advertisers while providing artists with valuable insights to connect with their audience.
RewardsPlus
Venture Round in 2005
RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.
Suros Surgical Systems
Venture Round in 2004
Suros Surgical Systems, Inc. is an Indiana-based medical device manufacturer recognized for its innovative approach to minimally invasive tissue excision and biopsy across various surgical specialties. The company has developed a patented surgical platform, highlighted by the ATEC™ (Automated Tissue Excision and Collection) breast biopsy and excision system, which represents significant advancements in vacuum-assisted diagnostic breast biopsy technology. Suros is unique in offering the only commercially available MRI-guided vacuum-assisted breast biopsy system, enabling early diagnosis for women in high-risk populations without surgical intervention. Additionally, the company provides specialized tools, including the first 9 gauge petite needle for small-breasted women and a true 12 gauge needle, designed to facilitate faster and less traumatic biopsy procedures. Suros emphasizes a commitment to improving patient care through innovations that enhance the speed, reliability, and safety of its procedures, aiming to reduce pain and scarring while eliminating recovery time. The company continues to seek new developments in minimally invasive techniques to further enhance surgical capabilities across multiple clinical applications.
Axya Medical
Venture Round in 2004
Axya Medical is a U.S.-based company based in Beverly, Massachusetts, specializing in the development of innovative medical instruments for surgical applications. Founded in 1996, the company focuses on knotless fixation systems for shoulder repair, which include a control unit, handpiece, wielding sleeve, and specialized sutures. In addition to these systems, Axya Medical offers a range of implants, such as titanium and bioabsorbable options, as well as various shoulder and general surgical accessories. These accessories include tools for removal, bone punching, and suture handling, all designed to enhance the effectiveness and efficiency of surgical procedures. Axya Medical is committed to advancing surgical techniques through its unique technology, which utilizes ultrasonic energy for welding surgical sutures.
FieldCentrix
Series B in 2004
FieldCentrix is a provider of mobile field service automation solutions aimed at enhancing service lifecycle management. Founded in 1994 and headquartered in Irvine, California, the company operates offices in North America and Europe. Its flagship product, FieldCentrix Enterprise, automates manual processes and consolidates various applications related to field service operations. The company’s technology encompasses an application suite that connects workflows, personnel, components, and data through a blend of real-time wireless communication and mobile device capabilities. FieldCentrix caters to diverse market sectors, including manufacturing, industrial equipment, medical devices, and building trade services, among others. In 2005, FieldCentrix became a subsidiary of Astea International Inc.
InSound Medical
Series D in 2004
InSound Medical, Inc. is a privately held company located in Newark, California, that specializes in the development and manufacturing of advanced hearing solutions. The company is known for its innovative product, Lyric, which is an invisible extended wear hearing device designed to provide discreet and convenient hearing assistance. InSound Medical is supported by notable investors, including Johnson & Johnson and various venture capital firms, reflecting its commitment to advancing hearing technology and improving the quality of life for individuals with hearing impairments.
Insulet Corporation, established in 2000, specializes in the development, manufacturing, and sale of insulin delivery systems for individuals with insulin-dependent diabetes. Its flagship product, the Omnipod System, comprises a self-adhesive, disposable, and tubeless device worn on the body for up to three days, along with a wireless, handheld personal diabetes manager. The company primarily sells its products through independent distributors, pharmacies, and directly to patients, with a presence in the United States, Canada, Europe, and the Middle East. Insulet's mission is to enhance the lives of people with diabetes by providing a user-friendly, pain-free, and automated insulin delivery solution.
PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company specializes in web-based direct data capture and management technologies that enhance data quality, facilitating more accurate and comprehensive information collection for biopharmaceutical and medical device companies. PHT's LogPad and StudyPad Systems streamline trial processes, while the robust StudyWorks online portal offers study sponsors, monitors, and sites real-time access to critical data. This enables faster decision-making and ultimately contributes to the success of clinical trials, making PHT an essential partner in the pharmaceutical and clinical research sectors.
LipoScience
Series E in 2003
LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.
InSound Medical
Series D in 2003
InSound Medical, Inc. is a privately held company located in Newark, California, that specializes in the development and manufacturing of advanced hearing solutions. The company is known for its innovative product, Lyric, which is an invisible extended wear hearing device designed to provide discreet and convenient hearing assistance. InSound Medical is supported by notable investors, including Johnson & Johnson and various venture capital firms, reflecting its commitment to advancing hearing technology and improving the quality of life for individuals with hearing impairments.
ZettaCom, Inc. manufactures and supplies chipset solutions to core multi-service switch and router original equipment manufacturers (OEMs).
Eunoe
Venture Round in 2003
Eunoe, Inc. is a San Francisco Bay-area medical device company focused on the treatment of neurological disorders through the management of cerebrospinal fluid.
Dynavax Technologies
Series D in 2002
Dynavax Technologies Corporation is a biopharmaceutical company specializing in the development and commercialization of innovative vaccines. Its flagship product, HEPLISAV-B, is a recombinant adjuvanted hepatitis B vaccine approved for use in adults aged 18 years and older, targeting all known subtypes of the hepatitis B virus. The company utilizes its proprietary Toll-like Receptor Immune Modulation Platform to enhance both innate and adaptive immune responses. Dynavax is actively advancing its immuno-oncology portfolio and has several development-stage products, including SD-101 and DV281, aimed at various cancer indications. In addition, the company engages in multiple research collaborations to develop adjuvanted vaccines for infectious diseases, including COVID-19, partnering with organizations such as Clover Biopharmaceuticals, the University of Queensland, and the Coalition for Epidemic Preparedness Innovations. Established in 1996 and headquartered in Emeryville, California, Dynavax continues to expand its role in vaccine development.
Broncus Medical
Series D in 2002
Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.
Standard BioTools
Series C in 2001
Fluidigm Corporation develops and markets innovative technologies and tools for life sciences research globally. The company specializes in integrated fluidic circuits that control fluids at the nanoscale, enabling a range of applications in biological research. Its product offerings include analytical systems such as the Helios CyTOF system, the Hyperion imaging system, and the Biomark HD system, along with various assays and reagents designed for immuno-oncology and genetic analysis. Fluidigm also provides preparatory instruments and single-cell microfluidics, such as the C1 and Polaris systems. The company serves a diverse clientele, including academic institutions, clinical research laboratories, biopharmaceutical, biotechnology, and agricultural biotechnology companies, focusing on non-diagnostic and non-clinical applications. Established in 1999 as Mycometrix Corporation, it adopted the name Fluidigm Corporation in 2001 and is headquartered in South San Francisco, California.
PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company specializes in web-based direct data capture and management technologies that enhance data quality, facilitating more accurate and comprehensive information collection for biopharmaceutical and medical device companies. PHT's LogPad and StudyPad Systems streamline trial processes, while the robust StudyWorks online portal offers study sponsors, monitors, and sites real-time access to critical data. This enables faster decision-making and ultimately contributes to the success of clinical trials, making PHT an essential partner in the pharmaceutical and clinical research sectors.
Oresis Communications
Venture Round in 2001
Oresis Communications designs and develops switching systems for carrying voice and data signals on the same telecommunications network. It offers ISIS-700 OmniService Switch, which enables carriers and service providers to migrate circuit and packet switched networks to a single backbone; and ISIS-700 Integrated OmniService Switch, which is a multiservice switch equipment that switches multiple voice, data, Internet, and video services in a single system. The company is based in Beaverton, Oregon.
Chameleon Systems
Series C in 2001
Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.
Lara Networks
Series B in 2000
Lara Networks is a fabless semiconductor manufacturer specializing in the design, development, and marketing of memory-intensive application-specific integrated circuits (ASICs) tailored for the networking and communications sectors. The company focuses on creating silicon-based packet processing solutions that enhance wide area network (WAN) infrastructure equipment. Additionally, Lara Networks provides advanced network search engines, further solidifying its position as a key player in the semiconductor industry for networking applications.
PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company specializes in web-based direct data capture and management technologies that enhance data quality, facilitating more accurate and comprehensive information collection for biopharmaceutical and medical device companies. PHT's LogPad and StudyPad Systems streamline trial processes, while the robust StudyWorks online portal offers study sponsors, monitors, and sites real-time access to critical data. This enables faster decision-making and ultimately contributes to the success of clinical trials, making PHT an essential partner in the pharmaceutical and clinical research sectors.
RewardsPlus
Venture Round in 2000
RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.
DynamicSoft
Series B in 2000
DynamicSoft offers carrier-class infrastructure software designed for packet-based wireline and wireless communications networks. The company's solutions enable carriers and communications application service providers to implement telephony applications and converged services over Internet Protocol networks. Central to its offerings is the dynamicsoft Service Engine, which facilitates mobile carriers in delivering voice and data services over packet networks. This platform also provides a transition pathway to IP 3G network environments and supports a range of services, including voice, multimedia messaging, instant messaging, and presence. Additionally, it consolidates essential functions such as customer data storage, authentication, authorization, provisioning, and service interaction. Established in 1998, DynamicSoft is headquartered in East Hanover, New Jersey.
Instill
Venture Round in 2000
Instill Corporation specializes in providing spend intelligence solutions tailored for the foodservice industry. Founded in 1993 and headquartered in San Mateo, California, the company automates the collection of transactional and process-oriented data from its customers' trading partners through its supply chain information services. Instill offers a comprehensive suite of hosted applications designed to assist clients in managing essential business processes, including trade and food spend management, quality and regulatory compliance, promotion management, procurement, food safety, as well as vendor and product management. Its services cater to foodservice manufacturers, operators, and distributors, helping them optimize their operations and improve their overall efficiency.
Lifespire
Venture Round in 2000
Lifespire was created in late 1999 through the merging of 2 companies: Vida Healthcare and inspiria.com. Vida Healthcare, formed in 1996, has worked with hundreds of oncology doctors, nurses and allied health professionals to improve cancer care. Lifespire Their vision is to improve care through shared knowledge. But what does that mean to you, the patient, and your circle of family and friends They serve? It means that They are giving you and the ones closest to you -- your circle of care -- a resource for gathering credible knowledge, support and understanding of your experience with cancer. Some of you may have known us when They were Vida Healthcare. In Their four years as Vida, They delivered clinical support and education services to over 4,000 people experiencing cancer. Now They're bringing that experience and understanding to you. They're doing this in partnership with companies committed to improving the treatment of cancer. And They're using Lifespire.com as Their forum for delivery.
RewardsPlus
Series D in 2000
RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.
Applicast
Venture Round in 1999
Applicast, Inc., founded in 1998 and privately held, specializes in providing comprehensive Application Service Provider (ASP) solutions for rapidly growing businesses. The company delivers full-service outsourcing for mission-critical applications like SAP and Siebel over secure internet connections. Applicast's unique offering includes a curated application portfolio, tailored FastFit™ Solutions, and end-to-end lifecycle services, enabling clients to expedite deployment while minimizing costs and risks.
Centromine
Venture Round in 1999
Centromine offers a browser-based, internet-accessed, enterprise-wide software applications and services for the health care market. Its applications allow behavioral health care programs and providers to manage the delivery and associated quality and cost of services completely over the internet.
PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company specializes in web-based direct data capture and management technologies that enhance data quality, facilitating more accurate and comprehensive information collection for biopharmaceutical and medical device companies. PHT's LogPad and StudyPad Systems streamline trial processes, while the robust StudyWorks online portal offers study sponsors, monitors, and sites real-time access to critical data. This enables faster decision-making and ultimately contributes to the success of clinical trials, making PHT an essential partner in the pharmaceutical and clinical research sectors.
HeartStent
Venture Round in 1999
HeartStent is a cardiovascular device firm. It is a direct revascularization device intended for coronary artery disease patients currently treated with coronary artery bypass grafts.
Chameleon Systems
Series B in 1999
Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.